When does Sai Life Sciences IPO subscription close?

Sai Life Sciences IPO subscription closes on 2024-12-13.

SAILIFEEQ / NSE, BSEListed

Sai Life Sciences

Sai Life Sciences Limited, incorporated in January 1999, specializes in researching, developing, and manufacturing small-molecule new chemical entities, serving over 280 innovator pharmaceutical companies in FY 2024, including more than 230 clients as of September 2024. Collaborating with 18 of the top 25 global pharmaceutical firms, the company provides services across the US, UK, Europe, and Japan, offering CMC/CDMO capabilities, integrated discovery through CRO services, and support in biology, chemistry, and pharmacokinetics. Supported by a workforce of 3,135 employees, including 2,353 scientific staff with 302 Ph.D.s and 1,475 master’s degrees, Sai Life Sciences drives innovation with a globally positioned business development team of 16 professionals.

drhp ANCHOR

₹522 - ₹54910.27x sub

Listed Price₹650.00

Listing Gain+18.40%

SAILIFEEQ / NSE, BSEListed

Sai Life Sciences IPO Subscription

Q: What is the live subscription status of Sai Life Sciences IPO?

Sai Life Sciences IPO has been subscribed 10.27x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and Retail Individual Investors.

drhp Document ANCHOR Document

Price Band₹522 - ₹549

Lot Size27 shares

Min Bid₹14,823

Subscription10.27x

Listed Market Snapshot

₹650.00Listed price from market data

+18.40%listing gain

Issue Amount

₹3,042.62 Cr

Listed Price

₹650.00

Current Price

₹1395.9

Registrar

Kfin Technologies Limited

Subscription Status

10.27xTotal Demand

Updated 20 Oct 2026, 01:30 AM

QIB29.78x

🔥 Blockbuster Sizzling Demand!Offered: 1,10,84,226 sh

Nib4.99x

Popular / Warm DemandOffered: 83,13,169 sh

Hnis(10l +)6.10x

Popular / Warm DemandOffered: 55,42,112 sh

Hnis (2-10l)2.78x

Fully Subscribed (Safe)Offered: 27,71,056 sh

Retail1.39x

Fully Subscribed (Safe)Offered: 1,93,97,393 sh

Category	Offered (Shares)	Applied (Shares)	Times Subscribed
QIB	1,10,84,226	33,01,25,058	29.78x
Nib	83,13,169	4,15,22,058	4.99x
Hnis(10l +)	55,42,112	3,38,13,693	6.1x
Hnis (2-10l)	27,71,056	77,08,365	2.78x
Retail	1,93,97,393	2,69,12,412	1.39x

Category	Offered	Applied	Times
QIB	1,10,84,226	33,01,25,058	29.78x
Nib	83,13,169	4,15,22,058	4.99x
Hnis(10l +)	55,42,112	3,38,13,693	6.1x
Hnis (2-10l)	27,71,056	77,08,365	2.78x
Retail	1,93,97,393	2,69,12,412	1.39x

Segment Subscription Demand

Segment / Category	Demand (Shares)	Offered (Shares)	Times Sub.
QIB	18,123.87	608.52	29.78x
Retail	1,477.49	1,064.92	1.39x
Hnis 2+	423.19	152.13	2.78x
Hnis 10+	1,856.37	304.26	6.10x

Application-wise Breakup

Category	Reserved	Applied	Times Sub.
Retail	7,18,422	9,96,756	1.39x
Hnis(10l +)	14,662	89,454	6.10x
Hnis (2-10l)	7,331	20,392	2.78x

Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Sai Life Sciences IPO Subscription Demand

Live subscription status and bidding analysis for Sai Life Sciences (SAILIFE) IPO. The issue is subscribed 10.27x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.